Back

Cardiopulmonary exercise testing predicts risk of progressive heart failure and long term mortality in ambulatory patients awaiting isolated heart transplant

31 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Added value of stress tests in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jonathan Afoke

Mayo Clinic Hospital-Rochester, Rochester (United States of America)

7 More presentations in this session

Presentation thumbnail
Assessment of cardiopulmonary exercise capacity in suspected heart failure with preserved ejection fraction: impact of coronary flow velocity reserve and body fat
Doctor S. Kim (Seoul, KR) Professor S. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Beyond resting measurements: exercise pulse pressure and its association with heart failure hospitalization
Doctor Y. Fu (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
O2 consumption overshoot in patients with heart failure: crossing the line.
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of symptom relief under low and normal physical performance in patients hospitalized for worsening heart failure
Doctor Y. Yamada (Yokohama, JP)
Abstract Slides Video
Presentation thumbnail
Exercise stress testing recovery kinetics: the forgotten phase.
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Added value of stress tests in heart failure

The Event

Event poster

ESC Congress 2024

31 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiopulmonary stress testing to guide transplant listing: what is the predictive accuracy of current criteria?
thumbnail
Congress Presentation
Peak VO2 and VE/VCO2 exhibit differential prognostic capacity for predicting cardiac events.
thumbnail
Congress Presentation
Predicting mortality in chronic heart failure: combined evaluation of VE/VCO2 and pVO2 independent of LVEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources